DFTX
Financials
- Market Capitalization 4.76 B
- Employee 106
- Founded 2010
- CEO Robert Barrow
- Website www.definiumtx.com
- Headquarter British Columbia, Canada
- FIGI BBG00F13HYQ7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1360 |  CRSP CRISPR Therapeutics AG - Common Shares | 50.63 USD | -5.10% | -18.52% | -0.73% | -10.23% | 4.88 B USD | ||
| 1372 |  LEGN Legend Biotech Corporation - American Depositary Shares | 25.75 USD | -4.91% | -8.72% | -27.51% | -19.48% | 4.76 B USD | ||
| 1395 |  VCYT Veracyte, Inc. - Common Stock | 57.48 USD | +0.90% | -1.93% | +21.16% | +55.77% | 4.59 B USD | ||
| 1424 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 41.27 USD | -9.12% | +1.90% | +16.45% | +170.98% | 4.44 B USD |
Frequently asked questions about Definium Therapeutics, Inc. - Common Shares
What is the Definium Therapeutics, Inc. - Common Shares stock price today?
The current price of Definium Therapeutics, Inc. - Common Shares (DFTX) is 43.65. Over the past 24 hours, the stock has changed by -7.27%. Follow the DFTX chart for real-time price dynamics.
What is the stock ticker of Definium Therapeutics, Inc. - Common Shares?
Definium Therapeutics, Inc. - Common Shares trades under the ticker DFTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Definium Therapeutics, Inc. - Common Shares stock going up?
DFTX has changed by -1.58% over the last week, +76.22% over the last month, and +188.88% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Definium Therapeutics, Inc. - Common Shares net income for the last quarter?
Definium Therapeutics, Inc. - Common Shares reported net income of -77.1 M for the last quarter. The previous quarter showed -50.44 M, which means net income changed by -52.86%.
How many employees does Definium Therapeutics, Inc. - Common Shares have?
As of the latest available data, Definium Therapeutics, Inc. - Common Shares has 106 employees. Workforce size can provide additional context about the company's scale and operations.
What is Definium Therapeutics, Inc. - Common Shares EBITDA?
Definium Therapeutics, Inc. - Common Shares EBITDA is -58.67 M, and its EBITDA margin is 133.35 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Definium Therapeutics, Inc. - Common Shares stock?
You can buy Definium Therapeutics, Inc. - Common Shares (DFTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Definium Therapeutics, Inc. - Common Shares stock?
Investing in Definium Therapeutics, Inc. - Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DFTX chart and related analysis on metatrader.com as part of your research.